Australian Machinery Stock News

Why Paladin Energy’s EIS approval matters for investors Paladin Energy (ASX:PDN) has secured Ministerial approval for its Environmental Impact Statement on the Patterson Lake South uranium project in Canada, a key regulatory step toward potential construction and eventual operation. The approval under Saskatchewan’s Environmental Assessment Act follows technical acceptance in June 2025 and a public review period from July to September. This clears an important hurdle before provincial and...

Charter Hall Group (ASX:CHC) is back in focus after upgraded fiscal 2026 guidance for higher post tax operating earnings and distribution growth, combined with strong half year results and the appointment of a new independent non executive director. See our latest analysis for Charter Hall Group. At a latest share price of A$22.07, Charter Hall Group has seen a 1 day share price return of 1.33%, while the 30 day and year to date share price returns of 6.20% and 9.70% compare with a 1 year...

Macquarie Technology Group (ASX:MAQ) opened H1 2026 with A$186.0 million in revenue and net income of A$16.9 million, translating to basic EPS of A$0.66 as investors weigh these results against a share price of A$67.89. The company reported revenue of A$182.0 million in H2 2024, A$183.6 million in H1 2025 and A$186.0 million in H2 2025, while basic EPS moved from A$0.74 to A$0.70 and then A$0.66 over the same periods. This provides a clear backdrop for how current margins are being...

Stanmore Resources reported its 2025 full-year results, with revenue easing to US$1,885.6 million and the company moving from a prior profit to a US$47.2 million net loss, while still declaring a fully franked final dividend of about US$0.089 per share payable in March 2026. Despite weaker earnings and softer coal prices, Stanmore lifted coal output to record levels, maintained strong liquidity, and confirmed stable coal reserves and resources, underscoring management’s confidence in the...

Transurban Group (ASX:TCL) has given investors fresh information to consider by combining a return to profitability in its latest half year, a reaffirmed distribution outlook, and a modest equity raise through its distribution reinvestment plan. See our latest analysis for Transurban Group. The recent half year return to profit, reaffirmed distribution guidance and fresh equity issued via the distribution reinvestment plan come as the share price trades at A$14.34, with a 1 month share price...

Investors may be wondering whether L1 Group at A$1.24 is offering good value right now, or if the recent buzz has already been priced in. The stock has returned 1.6% over the last 7 days, 5.5% over 30 days and 16.4% year to date, which may catch the eye of investors watching for shifting expectations and risk pricing. Recent coverage of L1 Group has focused on its role within the diversified financials space and how investors are assessing its current positioning. This helps to frame these...

Breville Group’s latest earnings event Breville Group (ASX:BRG) has drawn fresh attention after reporting a 10.1% uplift in first half FY26 revenue, record sales and steady EBIT growth, despite ongoing margin pressure from US tariffs. The company’s progress in shifting more than 80% of US gross profit dollars outside China, alongside continued spending on product development and AI-driven enterprise projects, is central to how many investors are now reassessing the stock. See our latest...

Karoon Energy (ASX:KAR) is back in focus after releasing its full year 2025 earnings, issuing production guidance for 2026, and declaring a new distribution to shareholders, giving investors fresh data to reassess the stock. See our latest analysis for Karoon Energy. Karoon Energy shares have come under pressure in the short term, with a 7 day share price return of a 10.95% decline and a 30 day share price return of an 8.04% decline around the earnings, guidance and new distribution news,...

Arafura Rare Earths (ASX:ARU) has drawn fresh attention after reporting a half year net loss of A$12.99 million, compared with A$18.85 million a year earlier, alongside recent director buying and upcoming employee option vesting. See our latest analysis for Arafura Rare Earths. The recent half year result, director share purchase update, and upcoming vesting of 197,000 employee options come against a backdrop where the latest share price of A$0.26 sits alongside a 1 year total shareholder...

Harvey Norman Holdings’ recent half‑year results showed net income of A$321.91 million and higher earnings per share, alongside a recommended fully‑franked interim dividend of A$0.145 per share for the six months to 31 December 2025, payable on 1 May 2026. At the same time, Harvey Norman has been named as a second defendant in a new class action over historical Interest Free Plan advertising, introducing a fresh layer of legal and reputational uncertainty around its consumer finance...

GPT Group (ASX:GPT) has attracted fresh attention after reporting full year 2025 earnings, with sales of A$815.8 million and net income of A$981 million, compared with a net loss of A$200.7 million a year earlier. See our latest analysis for GPT Group. At a latest share price of A$5.06, GPT Group’s short term share price returns have been soft, including a 30 day share price return of a 3.07% decline and a 90 day share price return of an 8.83% decline. Its 1 year total shareholder return of...

BlueScope Steel reported its half-year results for the period ended December 31, 2025, showing sales of A$8,251 million and net income of A$390.8 million, and it declared an unfranked interim dividend of A$0.65 per share, with an ex-dividend date of February 20, 2026 and payment due on March 24, 2026. The sharp increase in net income and earnings per share compared with the prior year, paired with the higher interim dividend, points to management’s confidence in the company’s current...

Ramsay Health Care Limited recently reported half-year 2026 results showing higher revenue of A$9,382.8 million and a return to net profit of A$160.7 million, and declared a fully franked interim dividend of A$0.425 per share payable on 26 March 2026. Alongside these results, Ramsay announced plans to separate its European arm Ramsay Santé through an in‑specie distribution and to acquire National Capital Private Hospital in Canberra, reshaping the group’s portfolio focus. With these stronger...

Aurizon Holdings has announced that Ian Wells, former Fortescue Metals Group CFO, will become its Chief Financial Officer and Group Executive Strategy from 7 April 2026, while acting CFO Gareth Long moves to lead Enterprise Services, and the company reported steady first-half 2026 earnings with A$2,104 million in revenue and A$235 million in net income. Alongside these leadership changes, Aurizon lifted its interim dividend to 12.5 cents per share and upgraded full-year 2026 dividend...

Worley Limited recently reported half-year 2026 results showing sales of A$1,028 million, revenue of A$5.53 billion, and net income of A$119 million for the six months ended 31 December 2025, alongside confirming an interim unfranked dividend of A$0.25 per share payable on 2 April 2026 and extending its share buyback plan to 12 March 2027. While profit and earnings per share fell compared to the prior period, Worley highlighted record bookings of A$9.8 billion and new major project wins...

Dateline Resources has recently acquired the Music Valley Heavy Rare Earths Project in California and applied for quotation of 300,000 new fully paid ordinary shares on the ASX under its DTR code. The deal not only adds heavy rare earths exposure, including minerals such as yttrium and dysprosium, but also links Dateline to broader US uranium and rare earth opportunities through its US$1.0 million equity investment in Fermi Critical Minerals. We’ll now look at how Dateline’s push into US...

4DMedical (ASX:4DX) is back in focus after its half-year results, where the company reported an improved adjusted net loss, a solid cash position, and highlighted its recently approved CT:VQ product. See our latest analysis for 4DMedical. At a latest share price of A$4.00, 4DMedical has seen a 12.68% 1 month share price return and a 133.92% 3 month share price return, while its 1 year total shareholder return is very large. This suggests momentum has been building around the CT:VQ rollout and...

Earnings, dividend and ESG penalties put Ampol in focus Ampol (ASX:ALD) is back on investors’ radar after reporting weaker 2025 earnings, announcing a new fully franked dividend and flagging higher future costs tied to missed emissions targets on its sustainability linked bonds. For the year to 31 December 2025, Ampol reported sales of A$31,365.5m and net income of A$82.4m, with basic earnings per share from continuing operations at A$0.346 and diluted EPS at A$0.345. Alongside these results,...

Bellevue Gold (ASX:BGL) has put fresh numbers on the table, with half year sales of A$268.73 million and net income of A$2.63 million, alongside approval for a new wet paste plant. See our latest analysis for Bellevue Gold. The latest earnings update and wet paste plant approval come after a strong 90 day share price return of 37.74% and a 1 year total shareholder return of 55.32%. This suggests momentum has picked up after earlier volatility. If Bellevue Gold has you looking at the broader...

Domino’s Pizza Enterprises recently reported half-year results to 28 December 2025, showing sales of A$1,101.8 million, a return to net profit of A$40.92 million, an interim dividend of A$0.25 per share, and board changes including the appointment of experienced quick service restaurant executive Drew O’Malley as an Independent Non-Executive Director effective 2 April 2026. The shift to lower discounting, which management links to reduced customer volumes but improved franchise partner...

Imdex Limited reported half-year 2025 results showing sales of A$246.59 million, net income of A$26.21 million, and declared a fully franked interim dividend of A$0.0169 per share, paid on 26 March 2026. The company’s record first-half performance, underpinned by strong demand for higher-margin technology, SaaS and sensor products, supported both earnings resilience and the decision to pay a record fully franked dividend. We’ll now examine how Imdex’s record first-half results and fully...

In recent weeks, Pro Medicus directors Sam Hupert, Anthony Barry Hall and Peter Terence Kempen each modestly increased their on-market shareholdings while the company secured a five-year A$10,000,000 contract with University Hospital Heidelberg and the German Cancer Research Institute. Together, these insider purchases and the new European hospital contract highlight management’s financial alignment with shareholders and ongoing commercial traction for Pro Medicus’s imaging software...

PEXA Group (ASX:PXA) is back in focus after revising its FY26 revenue guidance, lifting EBITDA margin guidance and highlighting progress in its UK rollout, all alongside a major reshuffle in its institutional register. See our latest analysis for PEXA Group. Those updates appear to sit against gradually improving price momentum, with a 1-day share price return of 4.68% and year to date share price return of 11.79%, while the 1-year total shareholder return of 21.69% and 3-year total...

Catalyst Metals (ASX:CYL) has put solid numbers on the board for H1 2026, with revenue of A$276.3 million and basic EPS of A$0.23 alongside net income of A$59.7 million, setting a clear marker for its latest half year. The company has seen revenue move from A$133.8 million and a basic EPS loss of A$0.03 in H1 2024 to A$276.3 million and A$0.23 EPS in H1 2025. Trailing twelve month revenue sits at A$459.4 million with basic EPS of A$0.44, giving investors a clear view of recent earnings ahead...